A detailed history of Verition Fund Management LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 13,230 shares of OCGN stock, worth $10,187. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,230
Holding current value
$10,187
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.98 - $1.95 $12,965 - $25,798
13,230 New
13,230 $13,000
Q1 2024

May 14, 2024

SELL
$0.5 - $1.83 $185,000 - $677,100
-370,000 Reduced 92.5%
30,000 $49,000
Q2 2023

Aug 14, 2023

BUY
$0.45 - $0.88 $180,000 - $352,000
400,000 New
400,000 $216,000
Q4 2022

Feb 14, 2023

BUY
$1.11 - $1.87 $15,540 - $26,180
14,000 New
14,000 $18,000
Q4 2021

Feb 14, 2022

SELL
$4.38 - $15.67 $93,740 - $335,369
-21,402 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$6.36 - $8.51 $136,116 - $182,131
21,402 New
21,402 $154,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $167M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.